I Am Just a Support Teacher

After researching the technology of culturing hematopoietic stem cells in vitro two years ago, Tian Jiajia's name became a sensation on the Internet again.

The last time was to give leukemia patients hope of being cured.

This time, it directly solved the problem that AIDS cannot be cured.

On the Internet, netizens even called Tian Jiajia a girl scientist.

Leukemia patients who were cured because of her medicine called her the Goddess of Life.

On the Internet, many people are discussing whether Tian Jiajia will become the youngest Nobel Prize winner in medicine.

"I think Tian Jiajia may not win the award. The Nobel is an award made by white people, and the political bias is too serious."

Some people think Tian Jiajia has no way to win the Nobel Prize in Medicine.

The main reason is Nobel's political bias.

For the same two Nobel-nominated scientists, one is Chinese and the other is white, as long as the difference in scientific achievements between the two is not too large, the Nobel Prize winner must be white.

"I think Tian Jiajia will definitely be able to win the Nobel Prize in Medicine. If people who have solved two of the five terminal illnesses cannot win the Nobel Prize in Medicine, then does this Nobel Prize still have authority? The Nobel Prize is not official. I will slap myself in the face."

Some netizens believe that Tian Jiajia will definitely win the Nobel Prize in Medicine.

The reason is that Tian Jiajia's scientific research achievements are too important. If such a major scientific research achievement cannot be awarded, the authority of the Nobel Prize will be questioned.

——

Just after Tian Jiajia's drug passed the biological tests of several domestic biological laboratories, the stock prices of many foreign pharmaceutical companies with anti-AIDS drugs fell in response.

Even though there was no media coverage of this news in foreign countries, panic selling of shares in pharmaceutical companies still occurred.

For example, Gilead, which owns the most anti-AIDS drugs, saw its stock price plummet by one-third in just a few days.

Although due to the suppression of capital, some domestic news has not been widely disseminated abroad.

But this does not mean that the news will not be known to shareholders who hold shares in pharmaceutical companies, they are the people who care most about such news.

With the advent of specific AIDS drugs, it is only natural that the stock prices of these companies with a large number of anti-AIDS drugs plummeted.

Just like a few years ago, after the emergence of rheumatoid drugs, most of the companies in the world with patents for rheumatoid drugs saw their stock prices plummet.

Two years ago, the technology of culturing hematopoietic stem cells in vitro was invented, and the stock prices of most companies with patents for treating leukemia also plummeted.

This time, the specific drug for AIDS came out, so the pharmaceutical companies that developed anti-AIDS drugs naturally suffered the most.

"Fake! Fake! Fake squid! Who can kill Tian Jiajia for me, it's so annoying!"

SKY Biological Company, the largest shareholder of this company at this time, Henry Stephen is venting crazily in the office.

Henry's biological company mainly researched leukemia drugs and anti-AIDS drugs, but because of Tian Jiajia alone, the company almost went bankrupt.

For Tian Jiajia, Henry already hated her to the extreme.

Get rid of Tian Jiajia?

Such an idea popped up in Henry's mind.

too difficult!

Soon, Henry vetoed this idea. If it was in the United States, it might be very simple, just hire a few killers.

But it is simply impossible to assassinate a genius scientist in Red China.

And even if it succeeds, if the matter is revealed and caught, then the conflict between the two big countries is not something he can bear.

Just when Henry was thinking wildly, at this moment, a phone call came.

"Henry, my old man, I need your help with something." A man's voice came from the phone.

"Howard, what do you want me to do for you?" Henry asked on the phone.

"It's like this. I'm going to unite with pharmaceutical companies across the United States to have our federal government launch a monopoly investigation on China's Hexin Pharmaceutical Company." The other end of the phone said.

"It's a good idea, and I support you."

Hearing that they were going to join forces to let the government launch a monopoly investigation, Henry agreed without thinking about it.

In the past few years, several drugs of China Hexin Pharmaceutical Company have almost monopolized the US market, which has caused heavy losses to many pharmaceutical companies.

"Well, try your best to help contact other people, and I will try to contact as many people as possible." The other end of the phone said to Henry, and then hung up the phone.

————

Domestically, the time has entered mid-August.

On the Internet, the news about several top scorers in the college entrance examination has been completely suppressed by the news that Tian Jiajia has developed a special drug for AIDS.

The most heated discussion on the Internet now is the clinical trial effect of AIDS specific drugs.

On the Internet, many AIDS patients are trying to find ways to inquire and contact each other, hoping to become the first batch of clinical trial participants.

Regarding the recruitment of clinical experimenters, Tian Jiajia handed over this issue to Yang Xin

Yang Xin directly posted a Weibo on the Internet, and then asked AIDS patients to sign up on the event page of the Dream Scholarship APP.

In the first phase of clinical trials, 200 people will be selected, and Yang Xin will try his best to select some patients with very difficult families to participate in clinical treatment.

The selection method is also very simple, that is to ask the system to help, and twenty points are enough.

Zhou Fuchuan, 42 years old, has been suffering from AIDS for 15 years. Fifteen years ago, he got AIDS because of a girlfriend who was not in love.

Although the country distributes antiretroviral drugs to AIDS patients free of charge, and has a high reimbursement medical insurance policy, Zhou Fuchuan still spends a lot of money every year.

Since he got this disease, he has owed a lot of debts outside, and his relatives are afraid to meet him, and in the end they are even strangers.

His disease makes it difficult for him to find a job in the city, and he only lives on the country's subsistence allowance every year.

Many times, he had the idea of ​​suicide. He felt that the whole world had abandoned him. If it weren't for the country's care for people like them, he might not be able to hold on.

August this year was an extraordinary month, and he seemed to see the hope of life.

On this day, a patient told him that volunteers for AIDS specific drugs are now being recruited, and those who want to become volunteers can sign up on the event page of the Dream Scholarship APP.

After seeing the news, Zhou Fuchuan signed up very actively.

Before he signed up, the event page had already shown that 100,000 people had signed up, and he didn't know if he would be selected.

With anticipation, at the end of the third day, he found his name in the list of 200 volunteers.

At this moment, he jumped up happily.

"Brother, congratulations on being selected."

"Zhou Fuchuan, congratulations."

Many patients also saw the list, and some people who knew Zhou Fuchuan congratulated him one after another.

"Haha, thank you everyone! I'm a clinical volunteer now, and I don't know what the drug is like. When you use it, it must be a mature product without any safety hazards." Zhou Fuchuan replied to the group friends.

He was very happy, and after hastily packing up his things, he drove to the capital.

After arriving in the capital, he also successfully contacted the hospital where the clinical trial was held, the Capital Third People's Hospital.

The clinical trials of specific AIDS drugs will be conducted in the Third People's Hospital.

PS: My mother came back yesterday. She was too tired after working all day during the day. The two chapters are updated normally, so there will be no more updates. Thank you for your understanding.